Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for prevention of lung injury after coronary artery bypass surgery
ISRCTN13139487Phase 2Recruiting
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of metformin in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Belfast Health and Social Care Trust. Started Feb 2026; status: recruiting.
02
Drugs
metformin
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on ISRCTN13139487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13139487.